machine learning

Real-world diagnostic performance of blood-based biomarkers for Alzheimer’s disease: robust performance except after stroke and high charlson comorbidity index

Diagnostic Performance of Blood-Based Biomarkers Blood-based biomarkers have gained attention for their potential utility in diagnosing Alzheimer’s disease (AD), offering

Real-world diagnostic performance of blood-based biomarkers for Alzheimer’s disease: robust performance except after stroke and high charlson comorbidity index Read Post »

Scroll to Top